Preschoolers with
depression at baseline were more likely to have later depression rather than other psychiatric disorders.
Parental Bonding Inventory (PBI) scores at baseline were investigated as predictors of depression on the Edinburgh Postnatal Depression Scale (EPDS) at 4, 14 and 21 months after childbirth in mothers without
depression at baseline.
This indicates that participants with higher levels of
depression at baseline who received the intervention showed larger reductions in depression symptoms over the course of the study.
The clinic group had more indicators of severe
depression at baseline than the community group (see http://www.ebmentalhealth.com/supplemental for table).
The findings reported herein suggest that remission of maternal depression over 3 months is statistically significantly associated with reduction in children's current symptoms and diagnoses after controlling for the child's age and sex, baseline symptoms, socioeconomic status (annual household income), as well as severity of maternal
depression at baseline, mother's treatment setting, and the child's treatment status over the 3 - month follow - up.
In the clinical interview, 27 % of the group were found to have
depression at baseline.
In our analysis, the association of sugar intake and recurrent depression was attenuated by measures of body fatness in participants without doctor diagnosis of
depression at baseline supporting the hypothesis of an indirect effect mediated by adiposity26, 27,28 driving the association of sugar intake and recurrent depression.
In sensitivity analyses, main analyses were repeated by: (a) excluding participants with unknown or reported doctor diagnosis of
depression at each baseline (at phases 3 / 5/7 / 9: 166 / 156/193 / 209 individuals) and: (b) excluding participants with extreme values of sugar intake (> 7 SD) at phases 3 / 5/7 / 9: 5 / 3/4 / 4 individuals.
Excluding participants who reported a doctor diagnosis of
depression at each baseline strengthened the association (Model 4 for CMD after 5 years, Person observations = 10944; highest vs. lowest tertile OR; 1.25; 95 % CI 1.03, 1.50; P for trend = 0.02, Supplementary Table S2) and exclusion of person observations with extremely high sugar intakes did not affect the results.
In a study of 1002 cases and controls followed up for 12 years, those with gut disorders had elevated levels of anxiety and
depression at baseline, but also those with higher levels of anxiety and depression were more likely to have gut disorders at follow - up (17).
Not exact matches
At baseline, patients age 80 and older had a higher prevalence of hypertension, heart disease, osteoporosis and joint problems, but a lower BMI, and a lower prevalence of
depression and smoking.
A growing number of human studies suggest that a low plasma Aβ42 / Aβ40 ratio is a risk factor for major
depression, 45, 46 dementia47 and higher mortality.48 The Framingham Study also showed that increased plasma Aβ42: Aβ40 ratios are associated with decreased risk of AD and dementia.13 Thus, the higher Aβ42 / Aβ40 ratio observed in regular meditators
at baseline and the increase in this ratio from pre - to post intervention in the novice meditator and vacation groups may be salutary to brain health.
Various biological factors
at baseline appear to predict response to rTMS, including levels of certain molecular factors, blood flow in brain regions implicated in
depression, electrophysiological findings, and specific genetic polymorphisms.
The data came from roughly 70,000 women, none of whom suffered from
depression at the study's start, who had
baseline measurements taken between 1994 and 1998, and then again after a three - year follow - up.
Sensitivity analyses excluding extreme values of sugar intake and excluding person - observations with self - reported doctor diagnosis
at baseline attenuated the association of sugar intake from sweet food / beverages and recurrent
depression slightly (before P for tertile trend 0.003 after 0.022 and 0.010, respectively).
Further adjustments for central obesity and physical health (not shown), exclusion of 709 person - observations (377 in CES - D analysis) with reported doctor diagnosis of
depression and person - observations with extreme values of sugar intake
at baseline did not change the results.
About 44 % of participants who were CMD cases
at baseline of each cycle remained recurrent CMD cases, 47 % became recurrent
depression cases and 58 % recurrent clinical
depression cases.
This group may tend to report higher consumption
at study
baseline even in the absence of
depression at the time of the questionnaire, while having an increased risk of future
depression compared to other participants14, 15.
To minimize this bias, we excluded
at baseline 10 280 women with severe depressive symptoms and we computed the cumulative mean of caffeinated and noncaffeinated beverages with
at least a 2 - year latency; yet, we can not exclude the possibility that mild depressive symptoms were the common reason for low caffeine consumption and incident
depression.
This incidence is not directly comparable to that observed in unselected populations because to minimize reverse causation, we excluded women with severe depressive symptoms
at baseline, thus eliminating a group
at higher risk of
depression.
On the whole,
depression levels decreased between
baseline and follow - up, with 14 % of participants found to have
depression diagnosed through clinical interview
at follow - up (an average of two years later).
Youth
baseline and follow - up interviews assessed mental health — related quality of life using the Mental Health Summary Score (MCS - 12)(range of possible scores, 0 - 100), 48,49 overall mental health using the Mental Health Inventory 5 (MHI - 5)(range of possible scores, 5 - 30), 50 service use during the previous 6 months using the Service Assessment for Children and Adolescents51 adapted to incorporate items assessing mental health treatment by primary care clinicians, 52 and satisfaction with mental health care using a 5 - point scale ranging from very dissatisfied (1) to very satisfied (5).53 CIDI diagnoses of major
depression and dysthymia were evaluated
at baseline and follow - up.
At both
baseline and follow - up there was a high rate of depressive symptoms with one third of the group scoring 14 or more on the Beck
Depression Inventory (a questionnaire designed to measure severity of depressive symptoms).
The pre — post effect size (d) was 0.95, and pre — follow - up was 1.08, comparable to effect sizes published investigating face - to - face mindfulness interventions for depressive symptoms in those with diabetes, PTSD and cancer15, 56, 57 and online cognitive therapy interventions for depressive symptoms in a moderately depressed sample.27, 36 The change in PHQ - 9 is higher than effect sizes found for IAPT
depression and anxiety treatment where follow - up was
at 4 and 8 months (0.46 and 0.63, respectively) 3 where the IAPT sample started with higher
baseline depression scores.
Categorical outcomes for
depression (50 % decrease in
depression scores on symptom checklist and major
depression by structured clinical interview for DSM - IV) since
baseline assessment
at three and six month blinded outcome assessments in patients receiving usual care (n = 196), feedback only (n = 221), and care management (n = 196)
At 12 weeks, the intervention group adjusted mean score for depressive symptoms on the BDI - II was significantly lower than the control group by 5.8 points (95 % CI − 11.1 to − 0.5) after adjusting for
baseline depression scores, anxiety, sociodemographics, psychotropic medication use and clustering by practice.
All children of mothers whose
depression remitted after treatment and who themselves had no
baseline diagnosis for
depression remained free of psychiatric diagnoses
at 3 months, whereas 17 % of the children whose mothers remained depressed acquired a diagnosis.
Anxiety was measured using the Zung Self - rating Anxiety Scale, 16 and
depression was assessed using the Zung Self - rating Depression Scale17 at baseline as well as at fo
depression was assessed using the Zung Self - rating
Depression Scale17 at baseline as well as at fo
Depression Scale17
at baseline as well as
at follow - up.
Of the children with a diagnosis
at baseline, remission was reported in 33 % of those whose mothers»
depression remitted compared with only a 12 % remission rate among children of mothers whose
depression did not remit.
Depression rates had not fallen lower than those
at baseline by 9 months, although the ethnic difference remained (figure 1C, D).
Formal tests to determine if the above rates of changes in children's diagnoses varied with mothers» remission status were statistically significant (P =.02), and remained significant after further adjusting for maternal
depression severity
at baseline, maternal treatment setting, annual household income, and child treatment status during the 3 - month follow - up interval (P =.01).
In the comparison of behavioural therapy versus CBT or cognitive therapy, effect size varied according to
depression severity
at baseline, though this was not the case with behavioural therapy versus control.
The elevated 30 - month Center for Epidemiological Studies
Depression Scale scores in the intervention group were driven by a higher prevalence of depressive symptoms among the PP+HS group (a difference not present
at baseline).
Percentage of the Young - HUNT cohort (n = 7497) in receipt of long - term medical benefits
at different ages during follow - up according to self - reported anxiety and
depression symptom level
at baseline.
This result was likely to be attributable to unexplained high
depression scores in the intervention group parents
at baseline.
For example, variations in the still - face effect have been associated with mothers»
baseline sensitivity and interactive style, and the infants» later attachment classification
at age 1, internalizing (e.g.
depression, anxiety) and externalizing (e.g. aggression, impulsivity) behaviors
at 18 months, and behavior problems
at age 3.
At baseline, severe
depression (BDI score ≥ 10) was present in 27 men (14.4 per cent); mild depressive symptoms (BDI scores 5 — 9) in 73 (38.8 per cent); and no
depression (BDI score < 5) in 88 men (46.8 per cent).
It is unclear how dementia and
depression were assessed
at baseline.
Maternal
depression was measured with the abbreviated Center for Epidemiologic Studies Depression Scale at baseline, preschool, and kin
depression was measured with the abbreviated Center for Epidemiologic Studies
Depression Scale at baseline, preschool, and kin
Depression Scale
at baseline, preschool, and kindergarten.
It was hypothesized that preschool
depression would show homotypic continuity over the course of 24 months, evidenced by a greater likelihood of subsequent
depression when compared with rates observed in those with other psychiatric disorders and those without disorders
at baseline.
At baseline (start of study) and 2 and 5 years after completion of the rehabilitation program all participants were evaluated in terms of sick leave, pain rating (Visual Analogue Scale), the Disability Rating Index, Hospital Anxiety and
Depression Scale, and Stress Test.
At baseline, the Diagnostic Interview Schedule (DIS - III - R) and the Beck
Depression Inventory (BDI) were administered.
Mean (95 % confidence interval) scores on hospital anxiety and
depression scale and sleep problem questionnaire
at baseline and follow up
at three, six, and 12 months
Analyses controlled for
baseline scores on each outcome measure, as well as for both the youth's self - reported
depression and the severity score on a self - report screening measure for adolescent substance abuse,
at baseline.
Nevertheless, many families with known and measured risks for behaviour problems were recruited, with 39 % of the sample
at baseline reporting the risk factors of maternal
depression, anxiety, substance misuse, partner conflict, social isolation and / or financial problems.5
Degree of phobic avoidance, bodily sensations, anxiety cognitions, and
depression were assessed
at pretreatment,
baseline, and end of treatment and
at follow - up after 3 and 12 months.
In several prospective studies, our group
at Massachusetts General Hospital examined rates of
depression in children with ADHD.45 In a 4 - year follow - up, lifetime rates of comorbid
depression in children with ADHD increased from 29 %
at baseline to 45 %
at average age 15.
They were assessed
at baseline using the Hamilton Rating Scale for
Depression (HAM - D) and the Beck
Depression Inventory.
Measures administered to children
at baseline post-treatment, 6 - and 12 - month follow - ups included the Kiddie Schedule for Affective Disorders for School - age Children - Present and Lifetime Version (K - SADS - PL - PTSD) PTSD subscale, Children's
Depression Inventory (CDI), State - Trait Anxiety Inventory for Children (STAIC), and the Children's Attributions and Perceptions Scale (CAPS).
Where participants were not diagnosed with anxiety and
depression symptoms
at baseline, scores were compared against...